Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2019 | 02-2019 | 12-2018 | 11-2018 | 08-2018 | |
| Operating Expenses | 71 | 0 | 69 | 79 | 2 |
| Operating Income | -71 | N/A | -58 | -79 | -2 |
| Other Income | 410 | 0 | 610 | 342 | 20 |
| Pre-tax Income | 338 | 0 | 552 | 263 | 18 |
| Net Income Continuous | 338 | N/A | 307 | 263 | 18 |
| Net Income | $338 | $N/A | $552 | $263 | $18 |
| EPS Basic Total Ops | -0.01 | N/A | 0.10 | -0.02 | 0.00 |
| EPS Basic Continuous Ops | 0.13 | N/A | -0.03 | 0.10 | 0.01 |
| EPS Diluted Total Ops | -0.01 | N/A | N/A | -0.02 | 0.00 |
| EPS Diluted Continuous Ops | 0.13 | N/A | N/A | 0.10 | 0.01 |
| EBITDA(a) | $-71 | $N/A | $-69 | $-79 | $-2 |